- Trials with a EudraCT protocol (570)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
570 result(s) found for: Endothelial.
Displaying page 1 of 29.
| EudraCT Number: 2014-000254-11 | Sponsor Protocol Number: 33375 | Start Date*: 2014-03-28 |
| Sponsor Name:Department of Neurology | ||
| Full Title: ROLE OF ENDOTHELIAL INFLAMMATION IN DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM | ||
| Medical condition: Mulple Sclerosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002389-13 | Sponsor Protocol Number: | Start Date*: 2005-11-23 |
| Sponsor Name:Moorfields Eye Hospital | ||
| Full Title: Endothelial Lamellar Keratoplasty (ELK) with Tisseel adhesive. | ||
| Medical condition: Corneal endothelial failure, from Fuchs' corneal endothelial dystrophy, aphakic and pseudophakic bullous keratopathy and other causes. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-011397-14 | Sponsor Protocol Number: TUD-EPPSOR-039 | Start Date*: 2009-12-07 |
| Sponsor Name:Technical University of Dresden | ||
| Full Title: Effect of anti-TNF-alpha therapy on endothelial progenitor cells and endothelial dysfunction in patients with psoriasis without risk factors for atherosclerosis | ||
| Medical condition: Psoriasis vulgaris | ||
| Disease: | ||
| Population Age: Adults | Gender: | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-000551-15 | Sponsor Protocol Number: MTXa54 | Start Date*: 2005-09-05 |
| Sponsor Name:University of Dundee | ||
| Full Title: Effect of folic acid supplementation and allopurinol on endothelial function in patients with rheumatoid arthritis treated with methotrexate | ||
| Medical condition: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory polyarthritis associated with excess cardiovascular (CV) mortality. Hyperhomocysteinaemia is recognized as an independent CV risk fact... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-006234-34 | Sponsor Protocol Number: CD07/8396 | Start Date*: 2008-08-18 |
| Sponsor Name:University of Leeds | ||
| Full Title: 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: endothelial and endothelial progenitor cell function in men | ||
| Medical condition: Objectives:To investigate whether statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) improve endothelial dysfunction in healthy volunteers (men). Endothelial dysfunction is an ear... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-002490-19 | Sponsor Protocol Number: UKER-FECD-RIPA-01 | Start Date*: 2017-12-07 | |||||||||||
| Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
| Full Title: Prospective single-centre randomized observer-blind placebo-controlled parallel-group phase IIa clinical trial to investigate the safety and efficacy of ripasudil 0.4% eye drops after descemetorhex... | |||||||||||||
| Medical condition: Moderate to advanced Fuchs endothalial corneal dystrophy (FECD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-000174-25 | Sponsor Protocol Number: 101090401IN | Start Date*: 2023-03-17 | |||||||||||
| Sponsor Name:SANTEN INCORPORATED | |||||||||||||
| Full Title: A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehi... | |||||||||||||
| Medical condition: Fuchs Endothelial Corneal Dystrophy (FECD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-003775-21 | Sponsor Protocol Number: ALH2 | Start Date*: 2008-08-14 |
| Sponsor Name:Salford Royal Hospitals NHS Trust [...] | ||
| Full Title: Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis | ||
| Medical condition: Systemic sclerosis (also termed 'scleroderma') | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-001738-29 | Sponsor Protocol Number: RGHT000502 | Start Date*: 2009-03-20 |
| Sponsor Name:Belfast Health and Social Care Trust | ||
| Full Title: Renin angiotensin Aldosterone (RAAS) axis, endothelial function and hypertension: diagnostic strategies and therapeutic role of potassium supplementation | ||
| Medical condition: We are seeking to determine the effects of potassium supplementation vs placebo for 6 weeks on the renin-angiotensin-aldosterone axis and also endothelial function in subjects with 10-20% 10 year ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-000103-27 | Sponsor Protocol Number: Eylea-2014 | Start Date*: 2014-03-12 |
| Sponsor Name: | ||
| Full Title: Plasma levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept in patients with exudative age-related macular degeneration. | ||
| Medical condition: Exudative age-related macular degeneration (AMD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-014643-36 | Sponsor Protocol Number: MeBe/08/NEB-MICR/001 | Start Date*: 2010-04-23 |
| Sponsor Name:MENARINI Benelux NV/SA | ||
| Full Title: Effects Of The Administration Of Nebivolol Versus Carvedilol On Microcirculatory Endothelial Function, Arterial Stiffness And Wave Reflection In Healthy Volunteers” (NeCaMic-study) | ||
| Medical condition: Microcirculatory Endothelial Function, Arterial Stiffness And Wave Reflection | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-016855-23 | Sponsor Protocol Number: CD09/9088 | Start Date*: 2010-08-20 |
| Sponsor Name:University of Leeds | ||
| Full Title: Targeting systemic inflammation to improve endothelial function in obesity | ||
| Medical condition: Healthy volunteer trial in obese subjects (body mass index 30 or greater) in which the IMP will be used to reduce inflammation by inhibiting tumour necrosis factor(TNF)-α in order to assess the eff... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001196-46 | Sponsor Protocol Number: OPHT-240215 | Start Date*: 2015-05-15 | |||||||||||
| Sponsor Name:Medical University of Vienna | |||||||||||||
| Full Title: Effect of simvastatin withdrawal on ocular endothelial function | |||||||||||||
| Medical condition: endothelial dysfunction in cardiovascular diseases | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-002023-32 | Sponsor Protocol Number: Niaspan | Start Date*: 2007-10-05 |
| Sponsor Name:Charité - Universitätsmedizin Berlin | ||
| Full Title: Niaspan for the treatment of endothelial dysfunction in patients without hyperlipoproteinemia | ||
| Medical condition: Patients in this study do have symptomes like dyspnea, reduced maximum stress and do have a weakness feeling. We are analysing the endothelial function via the FMD-methode: Before and after a Niasp... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-001958-36 | Sponsor Protocol Number: SDX_01 | Start Date*: 2022-08-29 |
| Sponsor Name:Corporativo de Servicios Médicos Especializados S.A de C.V V (Centro Médico del Noroeste) | ||
| Full Title: Endothelial protection in convalecent COVID-19 patients. The effect of Sulodexide on serum levels of biomarkers for endothelial dysfunction. A prospective, randomized, placebo-controlled, investiga... | ||
| Medical condition: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by coronavirus 2 (SARS-CoV-2) and, thus, being a novel cause of sepsis and the the poor outcome of patients with sepsis was relat... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005045-17 | Sponsor Protocol Number: 74983 | Start Date*: 2022-04-05 |
| Sponsor Name:AMC | ||
| Full Title: Resuscitation for repair of endothelial permeability in endotoxemia | ||
| Medical condition: Acute critical illnes requiring volume resuscitation with fluids (e.g. Sepsis). | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-003861-34 | Sponsor Protocol Number: 0/2004 | Start Date*: 2005-06-08 |
| Sponsor Name:Department of Nuclear Medicine | ||
| Full Title: Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects | ||
| Medical condition: There is an association between insulin resistance and endothelial dysfunction which is thought to be a critical factor in the development of vascular disease and thus an important factor in the de... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-018619-14 | Sponsor Protocol Number: Lira-Vasc-001 | Start Date*: 2010-03-31 |
| Sponsor Name:ikfe GmbH | ||
| Full Title: Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus | ||
| Medical condition: Type 2 Diabetes Mellitus | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002579-17 | Sponsor Protocol Number: WR 01102004 | Start Date*: 2006-11-08 |
| Sponsor Name:Medizinische Klinik B, Herzzentrum Ludwigshafen | ||
| Full Title: A double-blind, randomised placebo controlled study of the effects of Acarbose on endothelial function, hemostatic and fibrinolytic plasmatic factors in patients with stable coronary artery disease... | ||
| Medical condition: 1. To study the effect of Acarbose treatment on endothelial function as a potential mechanism for the beneficial effects of better postprandial glycemic control in patients with impaired glucose to... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004450-28 | Sponsor Protocol Number: T109/2012 | Start Date*: 2013-02-18 | ||||||||||||||||
| Sponsor Name:University of Turku [...] | ||||||||||||||||||
| Full Title: Effect of chemotherapy on endothelial function in patients with testicular cancer | ||||||||||||||||||
| Medical condition: Testicular cancer | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male | |||||||||||||||||
| Trial protocol: FI (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
